Patent: 10,287,294
✉ Email this page to a colleague
Summary for Patent: 10,287,294
| Title: | Compounds for use in treating or preventing cancerous diseases |
| Abstract: | The invention relates to new compounds of formula (I) that are useful in medicine, specifically in treating or preventing cancerous diseases in a mammal, to pharmaceutical compositions comprising such compounds, optionally together with other pharmaceutically active compounds, or to pharmaceutical formulations comprising such compounds or pharmaceutical compositions. The invention further relates to methods of making these compounds. |
| Inventor(s): | Stellas; Dimitris (Athens, GR), Tamvakopoulos; Constantin (Athens, GR), Klinakis; Apostolos (Iraklio, GR), Efstratiadis; Argiris (Athens, GR), Cournia; Zoe (Kifissia, GR) |
| Assignee: | BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR) |
| Application Number: | 15/742,330 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,287,294
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | ⤷ Start Trial | 2036-07-08 |
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | June 21, 1989 | ⤷ Start Trial | 2036-07-08 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | June 04, 1986 | ⤷ Start Trial | 2036-07-08 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Start Trial | 2036-07-08 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
